Xiaoying Ying

3.8k citations
71 papers · 3.1k indexed · 1 hit paper · h-index 35

Impact in

Papers in

Xiaoying Ying

70 papers receiving 3.1k citations

Hit Papers

ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury 2020 · 266 citations
266202020262022202450100150200250

Peers

Xiaoying Ying
Comparison fields: 5 of 121
  • Pharmaceutical Science 383
  • Biomaterials 804
  • Nephrology 197
  • Molecular Medicine 118
  • Biomedical Engineering 857
Replace Xiaoling Xu with:
Xiaoling Xu China
Xia Cao China
Han Chang Kang South Korea
Xifan Mei China
Yi Zhao China
Ning Li China
Xueqiong Zhang China
Pieter J. Gaillard Netherlands
Xiaoying Ying relative to Xiaoling Xu China Xiaoling Xu's profile →
Citations per field
00.5×10×20×26.2×
Xiaoling Xu · 1×
Citations per year

Countries citing papers authored by Xiaoying Ying

Since Specialization
Citations

This map shows the geographic impact of Xiaoying Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Ying more than expected).

Fields of papers citing papers by Xiaoying Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Ying. The network helps show where Xiaoying Ying may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaoying Ying, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoying Ying Line = papers co-authored together Xiaoying Ying links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 202329
3 20231
4 202210
5 202116
6 2020161
7
ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury
Hit paper breakdown →
2020266
8 202026
9 202043
10 201956
11 201850
12 201835
13 201863
14 201877
15 201645
16 201529
17 2014140
18 201224
19
Release Characterization of Drugs in Hot-melt Pressure Sensitive Adhesive
20091
20 200954

About Xiaoying Ying

Xiaoying Ying is a scholar working on Pharmaceutical Science, Biomaterials, Nephrology, Molecular Medicine and Aging, having authored 71 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (19 papers), Nanoplatforms for cancer theranostics (11 papers), Advanced Drug Delivery Systems (8 papers), Advancements in Transdermal Drug Delivery (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers), RNA Interference and Gene Delivery (5 papers), Acute Kidney Injury Research (5 papers) and Lipid Membrane Structure and Behavior (5 papers). The work is most often cited by research in Pharmaceutical Science (383 citations), Biomaterials (804 citations), Nephrology (197 citations), Molecular Medicine (118 citations) and Biomedical Engineering (857 citations). Xiaoying Ying has collaborated with scholars based in China, Czechia and Japan. Frequent co-authors include Yongzhong Du, Jing Qi, Jian You, Gaofeng Shu, Xiaoling Xu, Xu-Qi Kang, Feiyang Jin, Di Liu, Saiping Jiang and Fuqiang Hu. Their work appears in journals such as International Journal of Pharmaceutics, RSC Advances, Biomaterials, Scientific Reports and Theranostics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026